SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3557 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2632Anyone have access or the gist of what was covered in this article? endpts.comFelix B-1/14/2019
2631<Why don't they offer to buy IBM's headquarters, which is close by.&gMiljenko Zuanic-1/12/2019
2630Why don't they offer to buy IBM's headquarters, which is close by. ItDewDiligence_on_SI-1/12/2019
2629First step... "Regeneron picks general contractor for $800 million expansioMiljenko Zuanic-1/12/2019
2628I am still ????(and confused) about REGN rising $1B, from nowhere. Like they havMiljenko Zuanic-1/10/2019
2627As expected, or not-expected (whatever), Sanofi did not give any update on 4Q peMiljenko Zuanic11/8/2019
2626CD28/CTLA-4/PD-1.....what and how on CD80/86: ncbi.nlm.nih.gov Article (work) Miljenko Zuanic-1/7/2019
26258K, 99.3-financial overview for 2018/19.... secfilings.nasdaq.com 2018 tax ratMiljenko Zuanic-1/7/2019
2624from 8K: <With regard to the BCMAxCD3 Program and the MUC16xCD3 Program, whenMiljenko Zuanic11/7/2019
2623wwwext.amgen.com RE: Repatha discount I guess AMGN is not harpy how is PCSK9 maMiljenko Zuanic-1/7/2019
2622The Qs were focused over Eylea/Dupi market dynamic (Eylea PD expansion, CMS partMiljenko Zuanic-1/7/2019
2621Can you elaborate? There is a lot of stuff going on there. I do not understandBiotech Jim-1/7/2019
2620JPM Q&A part of presentation was very good, IMW.Miljenko Zuanic-1/7/2019
2619Eylea 4Q US sale at $1.07B ($4.07B, ~10% y/y). IF exUS hold at 18% (y/y)...REGNMiljenko Zuanic-1/7/2019
2618Sanofi partnership is slowly disallowing. Good! Regn now need its own infrastrucMiljenko Zuanic-1/7/2019
2617Interesting reading from Steven Holtzman, CEO of Decibel Therapeutics, leadershMiljenko Zuanic-1/6/2019
2616EU Dupi price pressure (from competitors): fiercepharma.comMiljenko Zuanic-1/4/2019
2615evaluate.com Something from Sanofi side, on IO, that may be significant to bothMiljenko Zuanic-1/4/2019
2614Dupi TRx/NRx for last week of 2018 are out. IF trend hold, projection for 4Q-18Miljenko Zuanic-1/4/2019
2613koreabiomed.com Have no idea what impact this may have over Eylea EV?Miljenko Zuanic-1/4/2019
2612Saga over CMS Part B drug price control continue.Miljenko Zuanic-1/2/2019
2611I don't speak lawyer - can someone translate?Felix B-12/24/2018
2610Marry Christmas for those who celebrate and/or Catholic. This was released on 1Miljenko Zuanic-12/22/2018
2609I have no inclination to read this file. secfilings.nasdaq.com it is about $750MMiljenko Zuanic-12/18/2018
2608CMS Part B: biotech-now.orgMiljenko Zuanic-12/10/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News